
Releases
Roche Gains FDA Clearance for Rapid Vaginitis Diagnostic Test
The U.S. Food and Drug Administration has granted 510(k) clearance to Roche for its cobas BV/CV assay, a molecular diagnostic tool designed to simultaneously detect bacterial vaginosis and Candida vaginitis from a single swab, aiming to replace traditional, less precise methods like microscopy and pH testing.























